Use of alkylphosphocholines for the preventative treatment of protozoan diseases such as especially leishmaniasis

摘要

Disclosd herein is a use of the alkyiphosphocholine hexadecylphosphocholine (miltefosine) or octadecyl 1,1,-dimethylpiperidinio-4-yl phosphate (perifosine) for producing a medicament for the preventive treatment of leishmaniasis in humans by oral administration, the medicament being adapted to provide a total daily dose in the range from 10 to 250 mg of miltefosine or perifosine active ingredient orally over a period of from 2 weeks to 6 months.